Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hers vs Mirabel Meds

Hers
Graded #252

Higher grade

vs+6.399999999999999
Mirabel Meds
Graded #397

Lower grade

The verdict

Hers takes it — 63.9/100 to 57.5/100.

Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Women-focused telehealth brand from Hims and Hers offering compounded semaglutide on a 6-month plan.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHers +9
54
45
Dose & formulationHers +37
77
40
Clinical oversightMirabel Meds +8
71
79
Labs & monitoringMirabel Meds +2
52
54
FulfillmentMirabel Meds +2
81
83
Contract termsMirabel Meds +14
41
55
Hers · left barMirabel Meds · right bar

The numbers

MetricHersMirabel Meds
WeighScore63.9/10057.5/100
GradeCC
Scorecard rank#252#397
Semaglutide$199/mo (starting dose, compounded)Not disclosed
Tirzepatide$299/mo (starting dose, plus a separate fee, brand-name)Not disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Hers

Graded #252 · C

Strengths

  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Mirabel Meds

Graded #397 · C

Strengths

  • LegitScript certified with board-certified Internal Medicine physician oversight
  • Compounded semaglutide, tirzepatide, and GLP-1 microdose injection options
  • White-glove concierge — direct provider messaging, no automated bots
  • Cold-chain temperature-controlled delivery to all 50 states
  • Monthly clinical reviews and dose adjustments included with every plan

Where it loses points

  • Pricing not publicly disclosed — requires a consultation to receive a quote
  • Compounded medications are not FDA-approved individual drugs
  • No named pharmacy partner disclosed on public pages
  • Labs not mentioned on any public page — baseline bloodwork protocol unknown
  • Concierge positioning suggests premium pricing above market average

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard